Covira

Covira is a biotechnology company developing drugs that prevent diseases by modulating the bioactivity of the gut microbiome. This microbiology-focused company is based on the work of Dr. John Alverdy, M.D., a world authority on the molecular basis of post-surgical infections. Covira's platform technology has generated a lead asset (CS-0003) capable of modulating bacterial virulence and restoring microbial communities to prevent postoperative infections.